The global protein engineering market witnessed a remarkable rise, surging from $2.2 billion in 2022 to a projected $7.7 billion by 2032, with a robust Compound Annual Growth Rate (CAGR) of 13.2% between 2023 and 2032. This surge is attributed to the expanding applications across biopharmaceuticals, industrial sectors, and research domains. Notably, the escalation in cancer cases plays a pivotal role in propelling market growth, as protein engineering spearheads the development of novel therapeutics for combating cancer.
Furthermore, continuous advancements in protein engineering technologies, such as CRISPR-based approaches, directed evolution, and computational protein design, are driving the market growth. These technologies enable more precise and efficient manipulation of protein structures and functions.
Protein engineering accelerates drug development by providing tools to design and modify proteins for therapeutic purposes. In addition, rise in prevalence of chronic diseases, such as cancer, autoimmune disorders, and metabolic diseases, fuels the demand for innovative therapeutic solutions as engineered proteins offer targeted and personalized treatment options.
Request Sample Copy of Report:
https://www.alliedmarketresearch.com/request-toc-and-sample/1129
Protein engineering encompasses a plethora of techniques, including site-directed mutagenesis, recombinant DNA technology, and computational modeling, to tailor the structure and function of proteins. Its objectives are diverse:
- Enhancing Protein Stability and Solubility: Through structural modifications, protein engineering addresses issues of instability and insolubility, augmenting their utility in research and industrial applications.
- Modulating Enzyme Activity: By manipulating the enzyme’s active site, protein engineering facilitates the fine-tuning of enzyme activity or the introduction of new functionalities.
- Pioneering Novel Protein Functions: Amino acid sequence modifications unlock the potential for creating novel functions, paving the way for innovative therapeutics and industrial enzymes.
- Crafting Protein-based Materials: Leveraging proteins, novel materials with unique properties, such as self-assembling hydrogels or nanostructured materials, are engineered.
Inquire Before Buying:
https://www.alliedmarketresearch.com/purchase-enquiry/1129
The protein engineering market is experiencing significant growth, driven by advancements in biotechnology and increasing demand for protein-based therapeutics. This expansion is attributed to the rising adoption of protein therapeutics over traditional small-molecule drugs, owing to their higher specificity and efficacy in treating various diseases.
In addition to market growth, notable developments include Capgemini’s recent unveiling of a generative AI-driven methodology aimed at accelerating innovation in the bio economy. This approach has demonstrated potential in protein engineering applications, such as optimizing enzyme functions and designing novel proteins for therapeutic uses. Such technological advancements are expected to further propel the protein engineering market, offering innovative solutions across healthcare and industrial sectors.
This burgeoning field finds applications across diverse sectors like biotechnology, medicine, and materials science, continuously evolving to offer groundbreaking solutions to multifaceted challenges.
Key Market Players:
- Promega Corporation
- Amgen, Inc.
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- Jena Bioscience GmbH
- New England Biolabs, Inc.
- Creative Biolabs Limited
- Agilent Technologies, Inc.
- Thermo Fisher Scientific Inc.
- TAKARA HOLDINGS INC.
By Region:
- North America (U.S., Canada, Mexico)
- Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
- LAMEA (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
- Asia-Pacific (Japan, China, Australia, India, South Korea, Rest of Asia-Pacific)
Procure Complete Report:
https://www.alliedmarketresearch.com/checkout-final/eb75695e23367c87d693be879118bc9a
For more insights, delve into the comprehensive report, spanning 295 pages packed with profound insights, charts, tables, and figures, offering a comprehensive understanding of the market dynamics.
About Us:
Allied Market Research (AMR), a business-consulting arm of Allied Analytics LLP, delivers unparalleled “Market Research Reports” and “Business Intelligence Solutions” to global enterprises, aiding them in making informed strategic decisions for sustainable growth. Led by CEO Pawan Kumar, AMR is committed to furnishing high-quality data and insights, ensuring accuracy through extensive primary interviews and rigorous research methodologies.
Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various research data tables and confirms utmost accuracy in our market forecasting. Each and every us companies and this helps us in digging out market data that helps us generate accurate y data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
